The importance of accurate diagnosis of dengue fever

Future Virology

Volumn 7, Issue 1, 2012, Pages 53-62

  Wiwanitkit, Viroj ^a  

^a WIWANITKIT HOUSE   (Thailand)

Author keywords

correct; dengue; diagnosis; error; infection

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NONSTRUCTURAL PROTEIN 1; PARACETAMOL;

ACUTE BACTERIAL PHARYNGITIS; BLEEDING TENDENCY; BLOOD CELL COUNT; CHIKUNGUNYA; CLINICAL FEATURE; DELAYED DIAGNOSIS; DENGUE; DENGUE VIRUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE DURATION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTAXIS; FALSE POSITIVE RESULT; FLUID THERAPY; HEMOCONCENTRATION; HEPATOMEGALY; INFLUENZA; LABORATORY TEST; MELENA; NEUROLOGIC DISEASE; PATHOGENESIS; PETECHIA; PHARYNGITIS; PHYSICAL EXAMINATION; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SCREENING; SEROLOGY; SHOCK; VIRUS ISOLATION;

EID: 84555218357     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.11.129     Document Type: Review

References (94)

1. Ramos C. Biology of infection caused by the dengue virus. Salud Publica Mex. 31(1), 54-72 (1989).
2. Kantoch M, Nawrocka E. Dengue virus-selected problems. Postepy. Hig. Med. Dosw. 37(2), 113-140 (1983).
3. Hayes EB, Gubler DJ. Dengue and dengue hemorrhagic fever. Pediatr. Infect. Dis. J. 11(4), 311-317 (1992).
4. Preiser W. Tropical virus not only in the tropics. Treatment, epidemiology and diagnosis of tropical viral infections. Pharm. Unserer. Zeit. 39(1), 34-40 (2010).
5. Sutton RN. Why bother with arboviruses? J. Infect. 11(2), 99-102 (1985).
6. Howard CR. Viral haemorrhagic fevers: properties and prospects for treatment and prevention. Antiviral Res. 4(4), 169-185 (1984). (Pubitemid 14029469)
7. Halstead SB. Selective primary health care: strategies for control of disease in the developing world. XI. Dengue. Rev. Infect. Dis. 6(2), 251-264 (1984).
8. Schlesinger RW. Dengue viruses. Virol. Monogr. (16), 1-132 (1977).
9. Kaushik A, Pineda C, Kest H. Diagnosis and management of dengue fever in children. Pediatr. Rev. 31(4), E28-E35
10. Matsumoto T, Yamaguchi K. Dengue fever. Nihon Naika Gakkai Zasshi 1093(11), 2375-2381 (2004).
11. Kolyvanos Naumann U, Käser L, Vetter W. Dengue fever. Praxis (Bern 1994) 793(1-2), 3-8 (2004).
12. Rigau-Pérez JG. Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990-1991. Puerto Rico Association of Epidemiologists. Rev. Panam. Salud Publica 1(5), 381-388 (1997). (Pubitemid 27428427)
13. Crowell CS, Stamos JK. Evaluation of fever after international travel. Pediatr. Ann. 40(1), 39-44 (2011).
14. Guzman MG, Halstead SB, Artsob H et al. Dengue: a continuing global threat. Nat. Rev. Microbiol. 8(12 Suppl.), S7-S16 (2010).
15. Lupi O. Mosquito-borne hemorrhagic fevers. Dermatol. Clin. 29(1), 33-38 (2011).
16. Sumarmo. Dengue haemorrhagic fever. Paediatr. Indones. 19(7-8), 202-218 (1979).
17. Cardosa MJ. Dengue haemorrhagic fever: questions of pathogenesis. Curr. Opin. Infect. Dis. 13(5), 471-475 (2000).
18. Morita K. Dengue/dengue hemorrhagic fever. Nihon Rinsho 61(Suppl. 2), 302-305 (2003).
19. Shekhar KC, Huat OL. Epidemiology of dengue/dengue hemorrhagic fever in Malaysia-a retrospective epidemiological study 1973-1987. Part I: dengue hemorrhagic fever (DHF). Asia Pac. J. Public Health 6(2), 15-25 (1993).
20. Kumar R, Prakash O, Sharma BS. Intracranial hemorrhage in dengue fever: management and outcome: a series of 5 cases and review of literature. Surg. Neurol. 72(4), 429-433 (2009).
21. Mathew S, Pandian JD. Stroke in patients with dengue. J. Stroke Cerebrovasc. Dis. 19(3), 253-256 (2010).
22. de Souza LJ, Martins AL, Paravidini PC et al. Hemorrhagic encephalopathy in dengue shock syndrome: a case report. Braz. J. Infect. Dis. 9(3), 257-261 (2005). (Pubitemid 41657678)
23. Wiwanitkit V. A study on functional similarity between dengue non structural protein 1 and platelet integrin/adhesin protein, CD61. J. Ayub. Med. Coll. Abbottabad 18(3), 13-16 (2006).
24. Wiwanitkit V. Weak binding affnity of immunoglobin G, an explanation for the immune mimicking theory in pathophysiologic fndings in the recovery phase of dengue. Nanomedicine 1(3), 239-240 (2005). (Pubitemid 43963630)
25. Morens DM. Dengue fever and dengue shock syndrome. Hosp. Pract. (Off. Ed.) 17(7), 103-107, 110-113 (1982).
26. Docquir J, Tuerlinckx D, Bodart E. Dengue shock syndrome. Rev. Med. Liege 64(11), 548-551 (2009).
27. Devignot S, Tolou H, Couissinier-Paris P. Dengue shock syndrome: decoding the pathophysiology. Med. Trop. (Mars) 70(3), 288-301 (2010).
28. Deparis X, Maréchal V, Matheus S. Pathophysiological mechanisms of dengue fever: critical review of current concepts. Med. Trop. (Mars) 69(4), 351-357 (2009).
29. Rajapakse S. Dengue shock. J. Emerg. Trauma Shock 4(1), 120-127 (2011).
30. Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr. Crit. Care. Med. 12(1), 90-100 (2011).
31. Guzmán Tirado MG. Dengue. II. Laboratory diagnosis. Immunity Epidemiology Rev. Cubana Med. Trop. 32(3), 191-196 (1980).
32. Wiwanitkit V Dengue fever: diagnosis and treatment. Expert Rev. Anti Infect. Ther. 8(7), 841-845 (2010).
33. Mirzaian E, Durham MJ, Hess K, Goad JA. Mosquito-borne illnesses in travelers: a review of risk and prevention. Pharmacotherapy 30(10), 1031-1043 (2010).
34. Wiwanitkit V. Bleeding and other presentations in Thai patients with dengue infection. Clin. Appl. Thromb. Hemost. 10(4), 397-398 (2004). (Pubitemid 39391302)
35. Wiwanitkit V. The tourniquet test is still a good screening tool for dengue illness. Trop. Doct. 35(2),127-128 (2005). (Pubitemid 40863173)
36. Díaz-Quijano FA. Predictors of spontaneous bleeding in dengue patients: a systematic review of the literature. Invest. Clin. 49(1), 111-122 (2008).
37. Chairulfatah A, Setiabudi D, Ridad A, Colebunders R. Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia. Ann. Soc. Belg. Med. Trop. 75(4), 291-295 (1995).
38. Norlijah O, Khamisah AN, Kamarul A, Paeds M, Mangalam S. Repeated tourniquet testing as a diagnostic tool in dengue infection. Med. J. Malaysia 61(1), 22-27 (2006). (Pubitemid 43667241)
39. Cao XT, Ngo TN, Wills B et al. Evaluation of the World Health Organization standard tourniquet test and a modifed tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop. Med. Int. Health 7(2), 125-132 (2002). (Pubitemid 34146789)
40. Mitrakul C. Bleeding problem in dengue haemorrhagic fever: platelets and coagulation changes. Southeast Asian J. Trop. Med. Public Health 18(3), 407-412 (1987).
41. Wiwanitkit V, Manusvanich P. Can hematocrit and platelet determination on admission predict shock in hospitalized children with dengue hemorrhagic fever? A clinical observation from a small outbreak. Clin. Appl. Thromb. Hemost. 10(1), 65-67 (2004). (Pubitemid 38543720)
42. Ito M, Takasaki T Diagnostic tests: dengue virus. Nihon Rinsho 63(Suppl. 7), 313-317 (2005).
43. Guzmán MG, Vázquez S. Notes on the laboratory diagnosis of dengue virus. Rev. Cubana Med. Trop. 54(3), 180-188 (2002).
44. Guzmán MG, Kourí G. Dengue diagnosis, advances and challenges. Int. J. Infect. Dis. 8(2), 69-80 (2004). (Pubitemid 38166073)
45. Kowitdamrong E, Thammaborvorn R, Semboonlor L, Mungmee V, Bhattarakosol P. Detection of dengue HI and IgM antibody: is it diagnostically useful? When and how? J. Med. Assoc. Thai 84(Suppl. 1), S148-S154 (2001). (Pubitemid 33714847)
46. Teles FR, Prazeres DM, Lima-Filho JL. Trends in dengue diagnosis. Rev. Med. Virol. 15(5), 287-302 (2005). (Pubitemid 41345364)
47. Conceição TM, Da Poian AT, Sorgine MH. A real-time PCR procedure for detection of dengue virus serotypes 1, 2, and 3, and their quantitation in clinical and laboratory samples. J. Virol. Methods 163(1), 1-9 (2010).
48. Chippaux A, Deubel V Application of the polymerase chain reaction (PCR) to diagnosis in virology. Bull. Soc. Pathol. Exot. 84(5 Pt 5), 704-711 (1991).
49. Peh AE, Leo YS, Toh CS. Current and nano-diagnostic tools for dengue infection. Front. Biosci. (Schol. Ed.) 13, 806-821 (2011).
50. Datta S, Wattal C. Dengue NS1 antigen detection: A useful tool in early diagnosis of dengue virus infection. Indian J. Med. Microbiol. 28, 107-110 (2010).
51. Watthanaworawit W, Turner P, Turner CL et al. A prospective evaluation of diagnostic methodologies for the acute diagnosis of dengue virus infection on the Thailand-Myanmar border. Trans. R. Soc. Trop. Med. Hyg. 105(1), 32-37 (2011).
52. Guzman MG, Jaenisch T, Gaczkowski R et al. Multi-country evaluation of the sensitivity and specifcity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl. Trop. Dis. 4(8), PII E811 (2010).
53. Hu D, Di B, Ding X et al. Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection. Virol. J. 8, 47 (2011).
54. Huhtamo E, Hasu E, Uzcategui NY et al. Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology. J. Clin. Virol. 47, 49-53 (2010).
55. De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz. J. Infect. Dis. 8(6), 390-398 (2004).
56. Low JG, Ong A, Tan LK et al. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl. Trop. Dis. 5(5), E1191 (2011).
57. Gulati S, Maheshwari A. Atypical manifestations of dengue. Trop. Med. Int. Health 12(9), 1087-1095 (2007) (Pubitemid 47421842)
58. Kamath SR, Ranjit S. Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India. Indian J. Pediatr. 73(10), 889-895 (2006).
59. Berlioz-Arthaud A, Gurusamy A. Comparison of PanBio dengue IgM ELISA assay with pentax dengue IgM particle agglutination assay to evaluate factors affecting false positive results. Southeast Asian J. Trop. Med. Public Health 39(1), 55-61 (2008).
60. Prince HE, Yeh C, Lapé-Nixon M. Development of a more effcient algorithm for identifying false-positive reactivity results in a dengue virus immunoglobulin M screening assay. Clin. Vaccine Immunol. 15(8), 1304-1306 (2008).
61. Schwartz E, Mileguir F, Grossman Z, Mendelson E. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. J. Clin. Virol. 19(3), 169-173 (2000).
62. Iffy L, Portuondo N, Raju V, Riley M. Incidents of catastrophic overhydration (maternal and neonatal) identifed through medico-legal reviews. Med. Law 27(4), 731-742 (2008).
63. Lahiri M, Fisher D, Tambyah PA. Dengue mortality: reassessing the risks in transition countries. Trans. R. Soc. Trop. Med. Hyg. 102(10), 1011-1016 (2008).
64. Janssen HL, Bienfait HP, Jansen CL et al. Fatal cerebral oedema associated with primary dengue infection. J. Infect. 36(3), 344-346 (1998). (Pubitemid 28291493)
65. Kangwanpong D, Bhamarapravati N, Lucia HL. Diagnosing dengue virus infection in archived autopsy tissues by means of the in situ PCR method: a case report. Clin. Diagn. Virol. 3(2), 165-172 (1995).
66. O'Brien BM. A practical approach to common skin problems in returning travelers. Travel Med. Infect. Dis. 7(3), 125-146 (2009).
67. Santiago A, Fernández-Sein A. Dengue in children: critical points in management. P. R. Health. Sci. J. 20(4), 343-346 (2001).
68. Costa Ade P, Bressan Cda S, Pedro RS et al. Delayed diagnosis of malaria in a dengue endemic area in the Brazilian extra-Amazon: recent experience of a malaria surveillance unit in state of Rio de Janeiro. Rev. Soc. Bras. Med. Trop. (5), 571-574 (2010).
69. Ward DI. A case of fatal Plasmodium falciparum malaria complicated by acute dengue fever in East Timor. Am. J. Trop. Med. Hyg. 75(1), 182-185 (2006) (Pubitemid 351627591)
70. Stephens HA. HLA and other gene associations with dengue disease severity. Curr. Top. Microbiol. Immunol. 338, 99-114 (2010).
71. Chaturvedi U, Nagar R, Shrivastava R. Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol. Med. Microbiol. 47(2), 155-166 (2006). (Pubitemid 43881735)
72. Leggat PA. Assessment of febrile illness in the returned traveler. Aust. Fam. Physician 36(5), 328-332 (2007).
73. Lo Re V 3rd, Gluckman SJ. Fever in the returned traveler. Am. Fam. Physician 68(7), 1343-1350 (2003). (Pubitemid 37221612)
74. Halstead SB, Lum LC. Assessing the prognosis of dengue-infected patients. F1000 Med. Rep. 1, PII 73 (2009).
75. Fernandez-Garcia MD, Mazzon M, Jacobs M, Amara A. Pathogenesis of favivirus infections: using and abusing the host cell. Cell Host Microbe 5(4), 318-328 (2009).
76. Soler M. Laboratory diagnosis to dengue virus infections. Acta Cient. Venez. 49(Suppl. 1), 25-32 (1998).
77. Houghton-Triviño N, Montaña D, Castellanos J. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Rev. Salud Publica (Bogota) 10(2), 299-307 (2008).
78. Schatzmayr HG. Dengue situation in Brazil by year 2000. Mem. Inst. Oswaldo Cruz 95(Suppl. 1), 179-181 (2000).
79. Zaki SA, Shanbag P. Clinical manifestations of dengue and leptospirosis in children in Mumbai: an observational study. Infection 38(4), 285-291 (2010).
80. Gushulak B, Funk M, Steffen R. Global changes related to travelers' health. J. Travel Med. 14(4), 205-208 (2007). (Pubitemid 47041475)
81. Valenstein PN, Sirota RL. Identifcation errors in pathology and laboratory medicine. Clin. Lab. Med. 24(4), 979-996, VII (2004).
82. Minato H, Nojima T, Nakano M, Yamazaki M. Safety management in pathology laboratory: from specimen handling to confrmation of reports. Rinsho Byori 59(3), 299-304 (2011).
83. Wiwanitkit V. Types and frequency of preanalytical mistakes in the frst Thai ISO 9002:1994 certifed clinical laboratory, a 6-month monitoring. BMC Clin. Pathol. 1(1), 5 (2011).
84. Stokol T, Erb HN. A comparison of platelet parameters in EDTA-and citrate-ant icoagu late d blood in dogs. Vet. Clin. Pathol. 36(2), 148-154 (2007). (Pubitemid 46925924)
85. Guzman Tirado MG, Flores GK, Bravo Gonzalez JR. Standardization of blood sample collection on flter paper for dengue serology Rev. Cub ana Med. Trop. 34(2), 114-118 (1982).
86. Silman E, Wirawan R, Timan IS, Setiabudy R, Aulia D, Sosrosumihardjo R. Country report: the Indonesian NEQAS on hematology. National External Quality Assessment Scheme. Southeast Asian J. Trop. Med. Public Health 30 (Suppl. 3), 12-14 (1999).
87. Lemmer K, Donoso Mantke O, Bae HG, Groen J, Drosten C, Niedrig M. External quality control assessment in PCR diagnostics of dengue virus infections. J. Clin. Virol. 30(4), 291-296 (2004). (Pubitemid 38649095)
88. Guzmán MG, Pelegrino JL, Pumariega T et al. Quality control of the serological diagnosis of dengue in laboratories throughout the Americas, 1996-2001. Rev. Panam. Salud Publica 14(6), 371-376 (2003). (Pubitemid 38121057)
89. Donoso Mantke O, Lemmer K, Biel SS et al. Quality control assessment for the serological diagnosis of dengue virus infections. J. Clin. Virol. 29(2), 105-112 (2004). (Pubitemid 38121581)
90. Domingo C, Niedrig M, Teichmann A et al. 2nd international external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl. Trop. Dis. 4(10), PII E833 (2010).
91. Teles FR, Prazeres DM, Lima-Filho JL. Trends in dengue diagnosis. Rev. Med. Virol. 15(5), 287-302 (2005). (Pubitemid 41345364)
92. Laposata M, Dighe A. 'Pre-pre' and 'post-post' analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin. Chem. Lab. Med. 45(6), 712-719 (2007). (Pubitemid 46956246)
93. Plebani M. The detection and prevention of errors in laboratory medicine. Ann. Clin. Biochem. 47(Pt 2), 101-110 (2010).
94. Tien SL. Validating the platelet count. Singapore Med. J. 36, 255-256 (1995).